Ph.D. Program in Toxicology

Graduate Student Seminars

TOX 558 – Spring Semester 2010
Selected Mondays, 12:00 noon.
K-307, Room 3-6408

May 3: Bethany Winans

Inappropriate Aryl Hydrocarbon Receptor Activation During Development Leads to Immune System Reprogramming.

May 3: Brittany Serke

Cell Type Specificity in Response to Engineered Nanoparticles Following in vitro Exposures.

April 26: Sadie Gorman

Organic Solute Transporter Ostα-Ostβ as a potential target for the treatment of obesity and its related disorders.

April 26: John Lapek

Defining a Prostate Cancer Drug Testing System Using Proteomics.

April 19: Bradley Buczynski

Evaluation of the Dose-Dependent Effects of Neonatal Hyperoxia on the Susceptibility of Adult Mice to Infection by Influenza A Virus.

April 19: Daniel Dever

The Aryl Hydrocarbon Receptor as a Putative Cell Cycle Regulator for Cerebellar Granule Neuron Progenitors: Implications for the Pathogenesis of Medulloblastoma

April 12: Chia Thach

Chemobrain: An Issue for Breast Cancer Patients?

April 5: Casey Manning

Endothelial Dysfunction Associated with Trans Fat Intake and its Impact on Atherosclerosis

March 29: Joseph Frasca

The Impact of the Microbiome on Health and Disease

March 22: Whitney Christian

When Mitochondrial Autophagy (Mitophagy) Doesn’t Work - Considerations for Genetic and Environmental Influences on the Pathogenesis of Parkinson’s Disease.

March 15: Kurt Bertram

Role of environmental xenobiotics in the pathophysiology of scleroderma.

March 1: Melissa Badding

Potential Mechanisms of Statin-induced Muscle Toxicity

February 22: Joshua Allen

Oxidative stress and inflammation in noise-induced hearing loss

February 8: Sarah Latchney

Dioxin interferes with neural precursor cell proliferation: Uncovering potential roles for the AhR during neurogenesis

February 1: Jennifer Head

Investigating the relationship between sustained AhR activation iNOS expression and neutrophil recruitment during influenza A virus infection

January 25: Ming Kung

The Aryl Hydrocarbon receptor as a Mediator of Bone Toxicity